Skip to main content
. Author manuscript; available in PMC: 2019 Jan 19.
Published in final edited form as: Clin Lung Cancer. 2018 Jun 28;19(5):450–456. doi: 10.1016/j.cllc.2018.06.004

Figure 2.

Figure 2.

Receiver operating curves (ROCs) for the developed miRNA (let-7c, miR-155, and miR-218 to predict the sensitivity of ponatinib (Figure 2A, on the left, AUC=0.853) and AZD4547 (Figure 2B, on the right, AUC=0.865) by using the IC50 cutoff values 50 nmol/l.